Subgroup analysis of participants with obesity categorized by severity of fatty liver disease and extent of pancreatic fat infiltration indicated that in patients with mild fatty liver, pancreatic fat severity minimally affected fasting blood glucose (Supplementary Figure S3), with no impact on insulin and C-peptide levels at any time point (Supplementary Figure S4, S5). This evidence concerns the gene INS and fatty liver disease.